William Anderson

William N.
Anderson is currently the Chief Executive Officer at Bayer AG since 2023.
He is also serving as the Director at Chugai Pharmaceutical Co., Ltd. since 2019 and as a Director at Pharmaceutical Research & Manufacturers of America.
Previously, he held the position of Chief Executive Officer & Director at Genentech, Inc. He was also the Chief Executive Officer at Roche Pharmaceuticals, Inc. from 2019 to 2022 and at Roche Pharma (Schweiz) AG from 2019 to 2023.
Prior to that, he worked as the Vice President-Neurology Unit at Biogen, Inc. from 2004 to 2006.
Mr. Anderson completed his graduate degree from Massachusetts Institute of Technology and his undergraduate degree from The University of Texas at Austin.